The problem with drug patents is that they end, leading to patent cliffs. That's when cheaper generic versions of a drug take ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

Alnylam Pharmaceuticals has announced a $250 million investment to expand its manufacturing facility in Massachusetts. The ...

Shares of Ventyx Biosciences gained after The Wall Street Journal reported that the company is in advanced talks to be acquired by Eli Lilly for about $1 billion. Ventyx shares were up 5.2%, to $8.23, ...

Eli Lilly is in advanced talks to buy Ventyx Biosciences for more than $1 billion, the Wall Street Journal reported on ...

The more-than-$1 billion deal could come imminently.

Eli Lilly and Nimbus Therapeutics have entered into a multi-year collaboration and exclusive licensing agreement to develop ...

It’s the latest move in the race by drug companies to corner more of the highly-lucrative obesity drug market.

Arrowhead’s experimental therapy helped patients on Lilly’s Zepbound lose more weight and visceral fat—but cost and ...

Indiana Attorney General Todd Rokita has filed lawsuit against one of the state’s most prominent companies, Eli Lilly and Co.

Attorney General Todd Rokita is intensifying his efforts to lower insulin prices and improve health care affordability for ...

Eli Lilly (NYSE: LLY) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in ...